---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-012731"
form_type: "8-K"
ticker: "VTAK"
cik: "0001716621"
company_name: "Catheter Precision, Inc."
filed_at: "2025-04-23T23:59:59+00:00"
generated_at: "2026-05-23T08:17:21.302170+00:00"
event_type: "m_and_a"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Catheter Precision acquires heart failure device assets; Q1 revenue up 73% to $142k

## Summary
- Subsidiary Cardionomix buys patents/trademarks for Cardionomic's CPNS System (acute decompensated heart failure).
- Purchase price: 1M restricted VTAK shares plus a $1.5M promissory note (4% interest, 3-year maturity).
- Closing conditions include NYSE American listing approval; deal must close by July 21, 2025.
- Preliminary Q1 2025 revenue $142k vs $82k YoY (+73%).
- Company warns it needs additional financing to develop assets; dilution expected.

## SEC filing metadata
- accession: 0001437749-25-012731
- form_type: 8-K
- ticker: VTAK
- cik: 0001716621
- company_name: Catheter Precision, Inc.
- filed_at: 2025-04-23T23:59:59+00:00
- event_type: m_and_a
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 2.01, 2.02, 8.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716621/000143774925012731/0001437749-25-012731-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716621/000143774925012731/vtak20250415_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-012731
- JSON: https://secwatch.observer/filing/0001437749-25-012731.json
- Plain text: https://secwatch.observer/filing/0001437749-25-012731.txt

## Key facts
- Debt Financings
  Catheter Precision, Inc. incurred loan of $1.5 million with Cardionomic (assignment for the benefit of creditors), LLC at 4% per annum maturing three years following issuance.
  - Instrument: loan
  - Principal: $1.5 million
  - Counterparty: Cardionomic (assignment for the benefit of creditors), LLC
  - Rate: 4% per annum
  - Maturity: three years following issuance
  - Event: incurrence
  source text: the issuance by Cardionomix of a promissory note (the "Note") in the amount of $1.5 million, with simple interest accruing at 4% per annum on the principal thereof and no interest or principal payable until the maturity date of the Note, which will be three years following issuance of the Note.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1716621/000143774925012731/0001437749-25-012731-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.